The 2020-2024 supply-chain disruptions — pandemic shortages, semiconductor scarcity, port congestion, Suez Canal blockage, Red Sea attacks — turned supply chains into a topic mainstream policymakers talk about explicitly. The frame "supply chains as strategic infrastructure" represents a shift from treating logistics as a private firm's concern to treating it as a national-security and public-policy concern.
What Changed
The post-Cold-War supply-chain paradigm prioritized efficiency over resilience. Just-in-time inventory management, single-sourcing of critical components, offshore concentration in low-cost producers (particularly China), and minimal redundancy were treated as operational best practices. The COVID-era stress tests revealed the fragility of these arrangements: a single-source supplier going offline could halt entire supply chains, and the resulting shortages could not be quickly remediated.
The semiconductor shortage that began in late 2020 and persisted through 2022 was the most consequential single example. US auto production was idled for months because of unavailable chips for engine control units that retail at a few dollars per chip. The aggregate economic cost of the shortage ran into the hundreds of billions of dollars across affected industries. The structural concern — that 90%+ of leading-edge semiconductor manufacturing is concentrated in Taiwan, with substantial geopolitical risk — moved from industry-specialist discourse into mainstream policy.
The Strategic Categories
Different supply chains pose different risks. The 2021-2024 US policy debates have effectively sorted them into categories:
Defense-critical components: semiconductors, rare earths, certain specialty chemicals, advanced manufacturing equipment. The risk is that supply disruption could constrain US military capacity in a crisis. The CHIPS Act and the rare-earths provisions of the Defense Production Act target these.
Public-health-critical components: active pharmaceutical ingredients, medical equipment, certain devices. The COVID PPE and ventilator shortages exposed the fragility. The Biomedical Advanced Research and Development Authority and various Defense Production Act invocations have been the response, though the structural changes have been modest.
Energy-transition-critical components: batteries, solar panels, wind turbines, critical minerals. The IRA's domestic-content requirements and the rare-earths investments target these. China's roughly 70% share of solar cell manufacturing and 60% share of battery manufacturing creates concentrated dependence that the US has been trying to diversify.
Consumer-staples chains: food, basic clothing, household goods. The fragility here is less about geopolitical risk than about climate- related disruption (droughts, floods, pest outbreaks). The response has been more limited and more market-driven.
The Reshoring vs. Friend-Shoring Debate
Two distinct policy frames have emerged. "Reshoring" — bringing production back to the US — appeals on national-security and employment grounds but is expensive and slow. Building a leading-edge semiconductor fab takes 4-5 years and tens of billions of dollars. The TSMC Arizona fab announced in 2020 began limited production in 2024 — useful but not large-scale.
"Friend-shoring" — relocating production to allied countries — is more politically pragmatic. The US has expanded sourcing from Mexico, Vietnam, Korea, Japan, and Taiwan. The benefit is faster than full reshoring and uses existing supplier ecosystems. The cost is that allies' political stability and trade-policy alignment can shift, which transfers but does not eliminate the dependence risk.
Neither full reshoring nor full friend-shoring is the operational reality. The actual pattern has been mixed: some reshoring for defense-critical components, more friend-shoring for general manufacturing, and continued Chinese sourcing for many categories where the cost differential remains substantial.
The Inventory Trade-Off
The shift from just-in-time to just-in-case inventory management trades capital-efficiency for resilience. Holding 90 days of strategic inventory rather than 30 days requires more working capital, more warehouse space, and accepts a lower return on invested capital. Most US firms have made some shift in this direction, but the long-run equilibrium will probably settle short of the levels that political discourse implies.
The reason is that inventory carrying costs are real and recurring. Once the immediate stress passes, the pressure to reduce inventory returns through standard return-on-capital calculations. The 2024 inventory levels are still elevated relative to 2019 but have fallen substantially from 2021-2022 peaks.
The Geographic Implications
Supply-chain reorganization has substantial geographic implications. Mexican manufacturing has grown rapidly under nearshoring trends. Vietnam, Thailand, Malaysia, and India have all absorbed shares of production that previously located in China. The "China + 1" strategy — keeping Chinese operations while diversifying to one or more alternative locations — has been the dominant private-sector response.
Within the US, supply-chain reorganization has concentrated investment in particular regions. The semiconductor cluster in Arizona, Ohio, and New York. The battery cluster in Tennessee, Georgia, and Michigan. The solar cluster in Texas and Florida. These are increasingly identifiable as strategic regions in the same way Detroit or Pittsburgh were in the twentieth century.
The Cost
The shift from efficiency-first to resilience-first supply chains has measurable costs. McKinsey's tracking has estimated that nearshoring and friend-shoring add roughly 15-25% to landed cost for typical manufactured goods. Some of that cost passes through to consumers; some is absorbed by margins; some is offset by government subsidies (the IRA, the CHIPS Act).
The political question is whether the resilience benefits justify the cost. The pandemic-era stress tests provide one data point: the cost of the shortages was substantial enough that some preventive investment in resilience is worthwhile. The harder question is how much, and what insurance value to assign to lower-probability disruptions like a Taiwan Strait crisis.
The Honest Reading
Supply chains are no longer purely operational concerns. They are strategic infrastructure that policy treats accordingly. The shift in US policy framing from 2019 to 2024 has been substantial — from hands-off treatment to active intervention through tariffs, subsidies, and procurement preferences. The empirical record on whether the interventions are producing the intended resilience is still being written. Some categories (semiconductors, rare earths) show progress. Others (active pharmaceutical ingredients, certain consumer staples) have seen less change. The 2030s will likely produce the test of whether the supply-chain reorientation can hold against the cost-efficiency pressure that originally produced the fragility.